12:00 AM
 | 
May 15, 2000
 |  BC Week In Review  |  Company News  |  Deals

Xerion Pharmaceuticals GmbH, Aventis Pharma Deutschland GmbH deal

Xerion will use its XCALIbur chromophore-assisted laser inactivation protein knockout technology to validate...

Read the full 42 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >